TITLE

Efficacy of fipronil-(S)-methoprene, metaflumizone combined with amitraz, and pyriprole commercial spot-on products in preventing Culex pipiens pipiens from feeding on dogs

AUTHOR(S)
Bouhsira, E.; Fysikopoulos, A.; Franc, M.
PUB. DATE
August 2009
SOURCE
Veterinary Record: Journal of the British Veterinary Association;8/1/2009, Vol. 165 Issue 5, p135
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A controlled clinical trial was carried out to assess the effectiveness of pyriprole, metaflumizone combined with amitraz, and fipronil-(S)-methoprene commercial spot-on products in preventing adult female Culex pipiens pipiens from feeding on dogs. Twenty-four beagle dogs were tested for their attractiveness to the mosquitoes and ranked accordingly to produce four groups of equivalent sensitivity to mosquitoes; six were treated with the pyriprole spot-on, six with the metaflumizone combined with amitraz spot-on, six with the fipronil-(S)-methoprene spot-on, and six were left untreated. All the dogs were challenged with 50 unfed adult female Culex in cages for one hour seven days before the treatment, and one and seven days after it. The mosquitoes were checked for blood feeding after one hour and for mortality 24 hours after they had been released into the cages. There was a significant reduction in the number of engorged mosquitoes only with the fipronil-(S)-methoprene product and there were significantly more dead mosquitoes with this product and the pyriprole product, but their effects were too small for them to be recommended for use in a dirofilariosis prevention programme.
ACCESSION #
43928767

 

Related Articles

  • Clinical Trials: A Retrospective.  // Applied Clinical Trials;Sep2010, Vol. 19 Issue 9, p8 

    The article offers information on several topics offered by the periodical "Applied Clinical Trials" in the clinical trials industry.

  • CE/CME questions.  // IRB Advisor;Jun2007, Vol. 7 Issue 6, p72 

    A quiz concerning medical research and clinical trials is presented.

  • Strengthening Protection for Trial Subjects.  // BioWorld Today;7/28/2011, Vol. 22 Issue 145, p5 

    The article reports on the plans to revise the Common Rule, a regulation that protects subjects involve in U.S. clinical trials and other human research, in order to address ambiguities and current needs in research as of July 28, 2011.

  • CME Questions.  // OB/GYN Clinical Alert;May2009, Vol. 26 Issue 1, p8 

    A quiz on medical topics is presented.

  • CNE/CME questions.  // Clinical Trials Administrator;Apr2009, Vol. 7 Issue 4, p48 

    A quiz about clinical trials is presented.

  • CNE/CME questions.  // Clinical Trials Administrator;Jan2009, Vol. 7 Issue 1, p12 

    A quiz about clinical trials is presented.

  • CNE/CME questions.  // Clinical Trials Administrator;Aug2009, Vol. 7 Issue 8, p96 

    A quiz about clinical trials is presented.

  • CE/CME questions.  // Clinical Trials Administrator;Apr2007, Vol. 5 Issue 4, p48 

    A quiz related to medical studies and research is presented.

  • CE/CME questions.  // Clinical Trials Administrator;Jun2007, Vol. 5 Issue 6, p72 

    A quiz concerning clinical trials administration is presented.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics